Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin, P. R. China.
Department of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, P. R. China.
World Neurosurg. 2021 Feb;146:298-306. doi: 10.1016/j.wneu.2020.11.121. Epub 2020 Nov 27.
We sought to evaluate the efficacy and safety of lumbar fusion versus nonoperative care for the treatment of chronic low back pain associated with degenerative disk disease.
A comprehensive duplicate electronic database search including PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure was conducted to identify relevant prospective studies published up to June 30, 2020. The main outcomes including clinical results, complications, and all-cause additional surgeries were presented in the form of short- (<2 years) and long-term (≥2 years) follow-up results. Analyses were performed in Review Manager software 5.3.
Six prospective studies involving 159 patients for short-term follow-up and 675 for long-term follow-up were included. The 2 interventions exhibited little difference in regard to short- and long-term Oswestry Disability Index and visual analog scale scores for back and leg pain, except that lumbar fusion might bring about lower additional surgery rate (risk ratio, 0.40; 95% confidence interval, 0.17 to 0.98; P = 0.04), and higher complication rate (risk ratio, 21.46; 95% confidence interval, 4.34 to 106.04; P = 0.0002) in the long term.
The present meta-analysis determined that fusion surgery was no better than nonoperative treatment in terms of the pain and disability outcomes at either short- or long-term follow-up. It is necessary for clinicians to weigh the risk of complications associated with fusion surgery against additional surgeries after nonoperative treatment. Considering lax patient inclusion criteria in the existing randomized clinical trials, the result needs to be further confirmed by high-quality research with stricter selection criteria in the future.
我们旨在评估腰椎融合术与非手术治疗对退行性椎间盘疾病相关慢性下腰痛的疗效和安全性。
通过全面的重复电子数据库搜索,包括 PubMed、Embase、Cochrane 图书馆和中国国家知识基础设施,检索截至 2020 年 6 月 30 日发表的相关前瞻性研究。主要结局包括临床结果、并发症和所有原因的附加手术,以短期(<2 年)和长期(≥2 年)随访结果的形式呈现。分析在 Review Manager 软件 5.3 中进行。
纳入了 6 项前瞻性研究,其中 159 例患者进行短期随访,675 例患者进行长期随访。两种干预措施在短期和长期随访的 Oswestry 残疾指数和腰背腿痛视觉模拟评分方面差异不大,但腰椎融合术可能会降低附加手术率(风险比,0.40;95%置信区间,0.17 至 0.98;P=0.04),并且长期并发症发生率更高(风险比,21.46;95%置信区间,4.34 至 106.04;P=0.0002)。
本荟萃分析确定融合手术在短期和长期随访的疼痛和残疾结局方面并不优于非手术治疗。临床医生有必要权衡融合手术相关并发症的风险与非手术治疗后的附加手术。考虑到现有随机临床试验中患者纳入标准较宽松,该结果需要在未来通过具有更严格选择标准的高质量研究进一步证实。